Fresh analysis suggests that patients who come off popular weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who end conventional diet and exercise programs.
Published data in a prominent medical journal demonstrates that while obese people often shed substantial amounts of their total mass while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month once they quit.
"Users purchasing these medications must be aware of the risk of rapid rebound weight gain when the treatment ends," warns lead investigator Dr. Susan Jebb.
Such speed of regain means a reversion to original mass in about 18 months.
Weighing Treatments
The analysis, which reviewed 37 of trials involving over 9,000 of participants, compared the effects of GLP-1 agonists with older methods.
Researchers point out that people who lose weight through dieting typically have a less rapid creep back—approximately 100 grams monthly—after stopping.
Understanding the Fast Regain
Nutrition scientists believe the way of the injections accounts for the accelerated weight return.
The injections mimic a natural hormone called GLP-1, which helps regulate hunger.
"Long-term administration of GLP-1 levels several times higher than normal may cause the system to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this medication means hunger is uncontrolled, making binge eating much more probable."
An Ongoing Disease?
The NHS suggest the injections for people with weight-linked health risks, alongside recommended lifestyle changes.
Professionals say that, given the likelihood of relapse, the therapy should be considered life-long.
This opinion is echoed by pharmaceutical companies, who note that the results "emphasize the persistent character of excess weight," similar to managing diseases like hypertension.
Patient Experiences
People who have discontinued the medication explain a intense resurgence of cravings.
"It felt as if a switch flipping and you're instantly starving," described one woman.
The struggle is exacerbated if patients have not established permanent lifestyle or habit changes during treatment.
Significant Adoption
Survey data suggest that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire remaining high.
- Adoption is higher among women than males.
- The middle-aged age group shows the greatest level of interest.
- A large proportion access the drugs through private prescriptions rather than the NHS.
Ultimately, researchers caution that while these medications are effective tools for weight loss, they are not a magic fix and long-term success hinges on combined behavioural support.
